Journal of Clinical Oncology

Being Present-CML: A mindfulness-based intervention for patients with chronic myeloid leukemia taking tyrosine kinase inhibitors.

Journal of Clinical Oncology

Kelly L. Schoenbeck, Anand Dhruva, Albert Lee, Anand Parikshak, Catherine Choy Smith, Neil P. Shah, Chloe Evelyn Atreya

Effect of breast tissue density on cell-free orphan non-coding RNAs secreted by breast cancers.

Journal of Clinical Oncology

Jeremy Ku, Akshaya Krishnan, Kim Hue Mai, Alice Huang, Dang D Nguyen, Selina Chen, Rose Hanna, Noura Tbeileh, Jieyang Wang, Xuan Zhao, Nae-Chyun Chen, Helen Li, Anna Hartwig, Fereydoun Hormozdiari, Pat Arensdorf, Lee S. Schwartzberg, Babak Alipanahi, Hani Goodarzi

Covalent-103: A phase 1, open-label, dose-escalation and expansion study of BMF-500, an oral covalent FLT3 inhibitor, in adults with acute leukemia (AL).

Journal of Clinical Oncology

Marcello Rotta, Yasmin Abaza, Hetty E Carraway, Bradley W. Christensen, Mitul Gandhi, Paul B. Koller, Ayman H. Qasrawi, Gary J. Schiller, Catherine Choy Smith, Uzma Ahmed, Alexandru Cacovean, Nicole Kowalczyk, Stephan W. Morris, Mona Vimal, Sauji Yachamaneni, Thomas Butler, Eunice S. Wang, Farhad Ravandi-Kashani

HLA associations with immunotherapy related endocrine toxicity.

Journal of Clinical Oncology

Zoe Quandt, Christian Thorball, Pooja Middha, Douglas Buckner Johnson, Cosmin A Bejan, Lydia Yao, Yaomin Xu, Flavia Hodel, Athina Stravodimou, Esther Shearer-Kang, Geoffrey Liu, Melinda C Aldrich, Adam Jacob Schoenfeld, Elad Ziv, Elizabeth J Phillips, Jacques Fellay, Ewa A Bergmann, G Scott Chandler, Justin M Balko, Ashis Saha

Association of germline polygenic risk for thyroid autoimmunity with overall survival in the I-SPY2 Trial.

Journal of Clinical Oncology

Kirkpatrick B Fergus, Pooja Middha, Zoe Quandt, Yiwey Shieh, Amrita B Basu, Rosalyn Sayaman, Paula R Pohlmann, Douglas Yee, Rebecca Arielle Shatsky, Claudine Isaacs, Michael J. Campbell, Gillian L. Hirst, Lamorna Brown Swigart, Laura van 't Veer, Elad Ziv, Laura Esserman

Harnessing cell-free orphan non-coding RNAs as a predictive measure of long-term survival in neoadjuvant breast cancer therapy.

Journal of Clinical Oncology

Taylor B. Cavazos, Mehran Karimzadeh, Amir Momen-Roknabadi, Gillian L. Hirst, Lamorna Brown Swigart, Christina Yau, Dang Nguyen, Alice Huang, Selina Chen, Rose Hanna, Akshaya Krishnan, Anna Hartwig, Jennifer Yen, Irene Acerbi, Fereydoun Hormozdiari, Diane Heditsian, Laura Esserman, Laura van 't Veer, Hani Goodarzi, Babak Alipanahi

CLDN18.2 chimeric antigen receptor T cell therapy for patients with advanced gastric and pancreatic adenocarcinoma: Results of ELIMYN18.2 phase 1b clinical trial.

Journal of Clinical Oncology

Gregory P. Botta, Ronan Joseph Kelly, Zhaohui Jin, Hong Ma, Geoffrey Yuyat Ku, Dan Zhao, Rutika Mehta, Julia C. Carnevale, Gloria Sierra, Jie JIA, Raffaele Baffa, Zhonghai Li, Dae Won Kim, Harry H. Yoon

Detection of early-stage cancers using circulating orphan non-coding RNAs in blood.

Journal of Clinical Oncology

Mehran Karimzadeh, Jeffrey Wang, Taylor B. Cavazos, Lee S. Schwartzberg, Michael Multhaup, Jeremy Ku, Xuan Zhao, Jieyang Wang, Kathleen Wang, Rose Hanna, Patrick Arensdorf, Kimberly H Chau, Helen Li, Hani Goodarzi, Lisa Fish, Fereydoun Hormozdiari, Babak Alipanahi

Consensus molecular subtypes and orphan non-coding RNAs in colorectal cancer.

Journal of Clinical Oncology

Jeffrey Wang, Mehran Karimzadeh, Taylor B. Cavazos, Afsaneh Barzi, Kathleen Wang, Rose Hanna, Patrick Arensdorf, Kimberly H. Chau, Helen Li, Hani Goodarzi, Lisa Fish, Fereydoun Hormozdiari, Babak Alipanahi

A phase 1/2 dose escalation study of the BCL-2 inhibitor ZN-d5 and the WEE1 inhibitor azenosertib (ZN-c3) in patients (Pts) with acute myeloid leukemia (AML).

Journal of Clinical Oncology

Catherine Choy Smith, Pankit Vachhani, Guillermo Garcia-Manero, Nicole Renee Grieselhuber, Guru Subramanian Guru Murthy, Astha Bhatia, Jatinder Arora, Hooman Izadi, Anthony Fiorino, Raajit Rampal

Pages